Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

UBXG vs LICN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

UBXG Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 4–3 Matrix Metrics)

UBXG Overall Winner 6-Pillar Tally: UBXG 3 – 2 LICN (1 Tie) Matrix Metrics: UBXG 4 – 3 LICN

As of Nov 20, 2026, U-BX Technology Ltd. (UBXG) is the stronger overall head-to-head candidate over Lichen China Limited Class A (LICN) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Balance Sheet & Cash Flow, Options & Positioning). UBXG carries a Unified Composite Score of 48.9/100 (HOLD) at $5.03 (N/M Forward P/E, -87.6% operating margin), whereas LICN carries 28.0/100 (SELL) at $1.29 (N/M Forward P/E, -87.1% operating margin).

  • Technical & Structure Timing Caution: UBXG trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.9); meanwhile LICN is in a Breakdown options structure phase (RSI 72.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About UBXG vs LICN
UBXG NASDAQ Head-to-Head Winner
U-BX Technology Ltd. Ordinary Shares
Services-Computer Programming, Data Processing, Etc.
$5.03
-0.2% 1D
Market Cap $9.2M
TTM Revenue $24M
Forward P/E N/M
Beta / 30D Vol 10.23β · 225% Vol
Unified Composite Score
48.9 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 48.9 · SMA20: $5.96 · SMA50: $4.05
LICN NASDAQ
Lichen China Limited Class A Ordinary Shares
Services-Management Consulting Services
$1.29
+8920.98% 1D
Market Cap $4,837
TTM Revenue $21M
Forward P/E N/M
Beta / 30D Vol -185.66β · 30914% Vol
Unified Composite Score
28.0 / 100 SELL
Tech 15.0 Fund 45.0 Flow 50.0 Mom 25.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 72
RSI-14: 72.3 · SMA20: $0.44 · SMA50: $0.77

6-Pillar Scorecard Institutional Category Breakdown (UBXG 3 – 2 LICN)

Columns: Metric · UBXG · LICN
1. Valuation Multiples UBXG
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.4x N/M
2. Growth & Scale LICN
Revenue Growth (YoY) -32.6% -28.0%
Earnings Growth (YoY) -88.4% -51.3%
TTM Revenue (USD) $24M $21M
Market Cap $9.2M $4,837
3. Profitability & Quality LICN
Gross Margin 0.3% 31.3%
Operating Margin -87.6% -87.1%
Net Profit Margin -55.1% -117.7%
Return on Equity (ROE) -46.6% -38.6%
4. Balance Sheet & Cash Flow UBXG
Cash Generation (TTM) -$13M EBITDA -$17M EBITDA
Cash Flow Margin -53.4% EBITDA Mgn -80.5% EBITDA Mgn
Net Cash / Leverage $30.52 Book/Sh · -46.6% ROE $372.85 Book/Sh · -38.6% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning UBXG
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Advertising Agencies Operator Specialty Business Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: UBXG (4) vs LICN (3)
Institutional Metric UBXG LICN Criterion Row Edge
Market Capitalization
Scale
$9.2M $4,837 Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-32.6% -28.0% Higher Growth LICN
Operating Margin (TTM)
Profitability
-87.6% -87.1% Higher Margin LICN
Net Profit Margin
Profitability
-55.1% -117.7% Higher Margin UBXG
Return on Equity (ROE)
Capital Efficiency
-46.6% -38.6% Higher ROE LICN
52-Week Range Position
Momentum
38% ($0–$13) 14% ($0–$9) Stronger Trend UBXG
Beta / 30D Volatility
Risk Regime
10.23β · 225% Vol -185.66β · 30914% Vol Lower Realized Risk UBXG
Unified Institutional Score
Composite Signal
48.9 / 100 (HOLD) 28.0 / 100 (SELL) Higher Composite UBXG
Trailing 12M Revenue (USD)
Operating Scale
$24M $21M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
0.3% 31.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.4x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$13M EBITDA ($30.52 Book/Sh · -46.6% ROE) -$17M EBITDA ($372.85 Book/Sh · -38.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon UBXG +12.39 pp
UBXG: -48.14% · LICN: -60.53%
3M Horizon UBXG +453.82 pp
UBXG: +379.05% · LICN: -74.77%
6M Horizon UBXG +220.04 pp
UBXG: +164.74% · LICN: -55.3%
1Y Horizon UBXG +189.57 pp
UBXG: +130.73% · LICN: -58.84%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UBXG vs LICN. Trailing 12-month operating profitability (UBXG -87.6% vs LICN -87.1%) and valuation multiples (UBXG N/M vs LICN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

UBXG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$24M
Gross Margin0.3%
Op. Margin-87.6%
ROE / Fwd P/E-46.6% · N/M
LICN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$21M
Gross Margin31.3%
Op. Margin-87.1%
ROE / Fwd P/E-38.6% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
UBXG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact UBXG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LICN BREAKDOWN
108d in phase · OBV DISTRIBUTION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact LICN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
UBXG Moat Profile Cyclical / Execution-Driven Positioning
Advertising Agencies Operator
Competes within the Advertising Agencies value chain with $9.2M market capitalization and -87.6% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
LICN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Business Services Operator
Competes within the Specialty Business Services value chain with $4,837 market capitalization and -87.1% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ UBXG vs LICN Key Questions & Quantitative Answers

As of Nov 20, 2026, U-BX Technology Ltd. (UBXG) is the stronger overall head-to-head candidate over Lichen China Limited Class A (LICN) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Balance Sheet & Cash Flow, Options & Positioning). UBXG carries a Unified Composite Score of 48.9/100 (HOLD) at $5.03 (N/M Forward P/E, -87.6% operating margin), whereas LICN carries 28.0/100 (SELL) at $1.29 (N/M Forward P/E, -87.1% operating margin). Technical & Structure Timing Caution: UBXG trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.9); meanwhile LICN is in a Breakdown options structure phase (RSI 72.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

LICN leads the Growth & Scale pillar: UBXG posts -32.6% YoY revenue growth and -88.4% YoY earnings growth on $24M TTM revenue (0.3% gross margin, -87.6% operating margin), compared with LICN at -28.0% YoY revenue growth and -51.3% YoY earnings growth on $21M TTM revenue (31.3% gross margin, -87.1% operating margin). On trailing 12-month operating scale, UBXG generates $24M in USD-normalized revenue versus $21M for LICN. In operating R&D and SG&A reinvestment, UBXG deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for LICN.

UBXG screens cheaper on headline valuation multiples. UBXG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.4x EV/Revenue (-53.4% EBITDA margin), whereas LICN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-80.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against UBXG (-46.6% ROE) versus LICN (-38.6% ROE) capital efficiency.

In options market volatility and institutional positioning, UBXG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (10.23β · 225% Vol realized risk). By comparison, LICN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (-185.66β · 30914% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.